Related references
Note: Only part of the references are listed.Pioglitazone Adjunctive Therapy for Moderate-to-Severe Major Depressive Disorder: Randomized Double-Blind Placebo-Controlled Trial
Khatereh Sepanjnia et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Forebrain glutamatergic neurons mediate leptin action on depression-like behaviors and synaptic depression
M. Guo et al.
TRANSLATIONAL PSYCHIATRY (2012)
Cognitive and neural correlates of depression-like behaviour in socially defeated mice: an animal model of depression with cognitive dysfunction
Tao Yu et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Adiponectin Stimulates Proliferation of Adult Hippocampal Neural Stem/Progenitor Cells through Activation of p38 Mitogen-activated Protein Kinase (p38MAPK)/Glycogen Synthase Kinase 3β (GSK-3β)/β-Catenin Signaling Cascade
Di Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Selective deletion of the leptin receptor in dopamine neurons produces anxiogenic-like behavior and increases dopaminergic activity in amygdala
J. Liu et al.
MOLECULAR PSYCHIATRY (2011)
Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice
E. Beurel et al.
MOLECULAR PSYCHIATRY (2011)
Antiobesity activities of indole-3-carbinol in high-fat-diet-induced obese mice
Hsiao-Pei Chang et al.
NUTRITION (2011)
Serum adiponectin and resistin levels in major depressive disorder
S. M. Lehto et al.
ACTA PSYCHIATRICA SCANDINAVICA (2010)
Inflammatory Biomarkers in 70 Depressed Inpatients With and Without the Metabolic Syndrome
Sara Zeugmann et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Low 24-Hour Adiponectin and High Nocturnal Leptin Concentrations in a Case-Control Study of Community-Dwelling Premenopausal Women With Major Depressive Disorder: The Premenopausal, Osteopenia/Osteoporosis, Women, Alendronate, Depression (POWER) Study
Giovanni Cizza et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Is Glycogen Synthase Kinase-3 a Central Modulator in Mood Regulation?
Xiaohua Li et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Reversal of Obesity and Insulin Resistance by a Non-Peptidic Glucagon-Like Peptide-1 Receptor Agonist in Diet-Induced Obese Mice
Min He et al.
PLOS ONE (2010)
Acute administration of leptin produces anxiolytic-like effects: a comparison with fluoxetine
Jing Liu et al.
PSYCHOPHARMACOLOGY (2010)
Long-Term Use of Antidepressants for Depressive Disorders and the Risk of Diabetes Mellitus
Frank Andersohn et al.
AMERICAN JOURNAL OF PSYCHIATRY (2009)
Antidepressant-like effects of rosiglitazone, a PPAR gamma agonist, in the rat forced swim and mouse tail suspension tests
Amany Ali Eissa Ahmed et al.
BEHAVIOURAL PHARMACOLOGY (2009)
Type of antidepressant therapy and risk of type 2 diabetes in people with depression
Lauren C. Brown et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Impact of increased PPARγ activity in adipocytes in vivo on adiposity, insulin sensitivity and the effects of rosiglitazone treatment
Katsuko Takasawa et al.
ENDOCRINE JOURNAL (2008)
The HPA axis in major depression: classical theories and new developments
Carmine M. Pariante et al.
TRENDS IN NEUROSCIENCES (2008)
Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program
Richard R. Rubin et al.
DIABETES CARE (2008)
Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions
Vaishnav Krishnan et al.
CELL (2007)
Detection of adiponectin in cerebrospinal fluid in humans
Markus Neumeier et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Improved ELISA for selective measurement of adiponectin multimers and identification of adiponectin in human cerebrospinal fluid
Hiroyuki Ebinuma et al.
CLINICAL CHEMISTRY (2007)
Adiponectin stimulates AMP-Activated protein kinase in the hypothalamus and increases food intake
Naoto Kubota et al.
CELL METABOLISM (2007)
Adiponectin complexes in human cerebrospinal fluid: distinct complex distribution from serum
C. M. Kusminski et al.
DIABETOLOGIA (2007)
The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis
S. Ali et al.
DIABETIC MEDICINE (2006)
Decreased plasma adiponectin concentration in major depression
Roberto Leo et al.
NEUROSCIENCE LETTERS (2006)
Area postrema neurons are modulated by the adipocyte hormone adiponectin
Mark Fry et al.
JOURNAL OF NEUROSCIENCE (2006)
Plasma levels of adiponectin and tumor necrosis factor-alpha in patients with remitted major depression receiving long-term maintenance antidepressant therapy
Kosuke Narita et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis
MJ Knol et al.
DIABETOLOGIA (2006)
Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress
O Berton et al.
SCIENCE (2006)
Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor γ agonists
AR Nawrocki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment
JL Warner-Schmidt et al.
HIPPOCAMPUS (2006)
Regulation of adiponectin expression in human adipocytes:: Effects of adiposity, glucocorticoids, and tumor necrosis factor α
M Degawa-Yamauchi et al.
OBESITY RESEARCH (2005)
Adiponectin - journey from an adipocyte secretory protein to biomarker of the metabolic syndrome
ME Trujillo et al.
JOURNAL OF INTERNAL MEDICINE (2005)
Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on β-catenin in mouse hippocampus
O Kaidanovich-Beilin et al.
BIOLOGICAL PSYCHIATRY (2004)
Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity
UB Pajvani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Effect of glucocorticoids on adiponectin: a study in healthy subjects and in Cushing's syndrome
F Fallo et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients
Y Miyazaki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Adiponectin acts in the brain to decrease body weight
Y Qi et al.
NATURE MEDICINE (2004)
Impaired multimerization of human adiponectin mutants associated with diabetes - Molecular structure and multimer formation of adiponectin
H Waki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
L Santarelli et al.
SCIENCE (2003)
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects
T Yamauchi et al.
NATURE (2003)
Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex
M Cnop et al.
DIABETOLOGIA (2003)
Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin - Implications for metabolic regulation and bioactivity
UB Pajvani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Adiponectin is stimulated by adrenalectomy in ob/ob mice and is highly correlated with resistin mRNA
H Makimura et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2002)
The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects
JG Yu et al.
DIABETES (2002)
Synthetic peroxisome proliferator-activated receptor-γ agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients
WS Yang et al.
DIABETES CARE (2002)
Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes
M Fasshauer et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
The prevalence of comorbid depression in adults with diabetes - A meta-analysis
RJ Anderson et al.
DIABETES CARE (2001)
Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia
C Weyer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Share Paper
